meropenem for injection powder for solution
sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems
meropenem for injection powder for solution
sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems
meropenem for injection sdz powder for solution
sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 500mg - meropenem (meropenem trihydrate) 500mg - carbapenems
meropenem for injection sdz powder for solution
sandoz canada incorporated - meropenem (meropenem trihydrate) - powder for solution - 1g - meropenem (meropenem trihydrate) 1g - carbapenems
meropenem and sodium chloride injection, solution
b. braun medical inc. - meropenem (unii: fv9j3ju8b1) (meropenem anhydrous - unii:yop6px0bao) - meropenem 500 mg in 50 ml - meropenem for injection and sodium chloride injection is indicated for the treatment of complicated skin and skin structure infections (csssi) due to staphylococcus aureus (methicillin-susceptible isolates only), streptococcus pyogenes, streptococcus agalactiae , viridans group streptococci, enterococcus faecalis (vancomycin-susceptible isolates only), pseudomonas aeruginosa, escherichia coli, proteus mirabilis, bacteroides fragilis, and peptostreptococcus species. meropenem for injection and sodium chloride injection is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci, escherichia coli, klebsiella pneumoniae, pseudomonas aeruginosa, bacteroides fragilis, b. thetaiotaomicron, and peptostreptococcus species. meropenem for injection and sodium chloride injection is indicated for the treatment of bacterial meningitis caused by haemophilus influenzae, neisseria meningitidis and penicillin-susceptible isolates of streptococcus pneumoniae . merope
meropenem eugia 500 mg inj./inf. sol. (pwdr.) i.v. vial
eugia pharma (malta) ltd. - meropenem trihydrate 570,78 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.78 mg - meropenem
meropenem eugia 1 g inj./inf. sol. (pwdr.) i.v. vial
eugia pharma (malta) ltd. - meropenem trihydrate 1141,56 mg - eq. meropenem 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1141.56 mg - meropenem
meropenem accord 1 g inj./inf. sol. (pwdr.) i.v. vial
accord healthcare b.v. - meropenem trihydrate 1140,95 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140.95 mg - meropenem
meropenem accord 500 mg inj./inf. sol. (pwdr.) i.v. vial
accord healthcare b.v. - meropenem trihydrate 570,474 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.474 mg - meropenem
meropenem mylan 500 mg inj./inf. sol. (pwdr.) i.v. vial
viatris gx bv-srl - meropenem trihydrate 570,78 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.78 mg - meropenem